$2.90
0.26[9.85%]
Last update: 7:53AM Get Real Time Here
LAVA Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of LAVA Therapeutics using advanced sorting and filters.
Date | time | ticker | Quarter | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|---|
06/06/2024 | AM | LVTX | Q1 | -$0.53 | — | — | — | $1.22M | — | — | — | Get Alert |
03/20/2024 | AM | LVTX | Q4 | -$0.57 | -$0.12 | -$0.24 | -100.00% | $2.64M | $6.25M | $353.00K | -94.35% | Get Alert |
11/16/2023 | AM | LVTX | Q3 | $0.04 | — | -$0.34 | — | $15.26M | — | $53.00K | — | Get Alert |
08/22/2023 | AM | LVTX | Q2 | -$0.31 | -$0.47 | -$0.48 | — | $468.00K | $830.00K | $5.14M | 519.16% | Get Alert |
06/08/2023 | AM | LVTX | Q1 | -$0.41 | -$0.52 | -$0.53 | -1.92% | $1.00M | — | $1.22M | — | Get Alert |
04/11/2023 | AM | LVTX | Q4 | -$0.32 | -$0.64 | -$0.57 | 10.94% | $1.00M | $250.00K | $2.64M | 956.00% | Get Alert |
11/16/2022 | PM | LVTX | Q3 | -$0.27 | -$0.15 | $0.04 | 126.67% | $2.10M | $10.53M | $15.26M | 44.93% | Get Alert |
09/13/2022 | PM | LVTX | Q2 | -$0.31 | -$0.60 | -$0.31 | 48.33% | $1.08M | $340.00K | $468.00K | 37.65% | Get Alert |
05/17/2022 | AM | LVTX | Q1 | -$12.29 | -$0.86 | -$0.41 | 52.33% | $1.11M | — | $1.00M | — | Get Alert |
03/24/2022 | AM | LVTX | Q4 | -$12.97 | -$0.40 | -$0.32 | 20.00% | $2.00M | — | $1.00M | — | Get Alert |
11/15/2021 | AM | LVTX | Q3 | -$8.43 | -$0.31 | -$0.27 | 12.90% | $827.00K | — | $2.10M | — | Get Alert |
08/16/2021 | AM | LVTX | Q2 | — | -$0.27 | -$0.28 | -3.70% | — | — | $1.08M | — | Get Alert |
05/20/2021 | AM | LVTX | Q1 | — | — | -$12.29 | — | — | — | $1.11M | — | Get Alert |
LAVA Therapeutics (LVTX) is scheduled to report earnings on June 6, 2024. The last reported earnings were for reported on March 20, 2024 for Q4.
The Actual EPS was $-0.24, which missed the estimate of $-0.12.
The Actual Revenue was $353K, which missed the estimate of $6.3M.
Browse earnings estimates, EPS, and revenue on all stocks.